Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News LINC 2023

FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA

L.A. McKeown

June 08, 2023

News Daily News

SAFE-AAA Flags Ongoing EVAR Device Risk and Urges More Surveillance

L.A. McKeown

March 16, 2023

News Daily News

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

L.A. McKeown

December 06, 2022

News Daily News

FDA Safety Communication Updates Stance on Endologix AAA Grafts

L.A. McKeown

January 13, 2022

News Daily News

FDA Reminder: Yearly, Lifelong Surveillance Needed for Endologix AAA Grafts

L.A. McKeown

December 04, 2020

News Daily News

FDA: New Concerns Surface With Endologix Grafts for AAA

L.A. McKeown

October 28, 2019

News Daily News

FDA: All AFX Endovascular AAA Systems Now Under Class I Recall

L.A. McKeown

October 16, 2018

News Industry News

Endologix Reports Positive 1-Year Results from the Ovation® LUCY Study

July 09, 2018

News Daily News

FDA Identifies Culprit in Endovascular Graft Type III Endoleaks

L.A. McKeown

June 19, 2018

News Conference News VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

L.A. McKeown

September 14, 2017

News Industry News

Endologix Announces First Patients Treated with Ovation Alto™ Abdominal Stent Graft System

August 18, 2016

News Industry News

Endologix Completes Patient Enrollment in the Ovation® LIFE (Least Invasive Fast-Track EVAR) Study

May 17, 2016

News Industry News

Endologix Announces First Patients in Japan Treated With Nellix® EndoVascular Aneurysm Sealing System

March 08, 2016

News Industry News

Endologix Announces First U.S. Commercial Implant of AFX®2 Bifurcated Endograft System

February 28, 2016

News Daily News

在医疗保险人口中，EVAR的早期生存优势在3年后失去

July 23, 2015

News Daily News

En la Población de Medicare, el Beneficio Precoz sobre la Supervivencia que ofrece EVAR Desaparece a los 3 Años

July 23, 2015

News Daily News

Un Injerto de Stent en Fase de Investigación resulta Prometedor en la EVAR de AAA Infrarrenales

L.A. McKeown

June 11, 2014

News Daily News

女性PAD患者更多采用血管内手术，院内死亡率更高

October 25, 2013

News Daily News

La EVAR Ambulatoria es una Opción para 1/3 parte de los Pacientes con AAA

Yael L. Maxwell

August 30, 2013

Advertisement

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA

SAFE-AAA Flags Ongoing EVAR Device Risk and Urges More Surveillance

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

FDA Safety Communication Updates Stance on Endologix AAA Grafts

FDA Reminder: Yearly, Lifelong Surveillance Needed for Endologix AAA Grafts

FDA: New Concerns Surface With Endologix Grafts for AAA

FDA: All AFX Endovascular AAA Systems Now Under Class I Recall

Endologix Reports Positive 1-Year Results from the Ovation® LUCY Study

FDA Identifies Culprit in Endovascular Graft Type III Endoleaks

EVAR Outcomes Equivalent Between Men and Women, Registries Show

Endologix Announces First Patients Treated with Ovation Alto™ Abdominal Stent Graft System

Endologix Completes Patient Enrollment in the Ovation® LIFE (Least Invasive Fast-Track EVAR) Study

Endologix Announces First Patients in Japan Treated With Nellix® EndoVascular Aneurysm Sealing System

Endologix Announces First U.S. Commercial Implant of AFX®2 Bifurcated Endograft System

在医疗保险人口中，EVAR的早期生存优势在3年后失去

En la Población de Medicare, el Beneficio Precoz sobre la Supervivencia que ofrece EVAR Desaparece a los 3 Años

Un Injerto de Stent en Fase de Investigación resulta Prometedor en la EVAR de AAA Infrarrenales

女性PAD患者更多采用血管内手术，院内死亡率更高

La EVAR Ambulatoria es una Opción para 1/3 parte de los Pacientes con AAA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content